Mahamaya Lifesciences Limited
BBSE:MAHALIFE169.00
INR
-3.55
(-2.06%)
ISIN
INE0U9D01019
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Krishnamurthy Ganesan
- Full Time Employees
- 71
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- Gurugram India
- IPO Date
- Nov 18, 2025
- Website
- mahamayalifesciences.com
- Similar Companies
- Business
- Mahamaya Lifesciences Limited is an India-based crop protection and life sciences company engaged in the research, development, manufacturing, and global distribution of agrochemical formulations and active ingredients. The company offers a comprehensive portfolio of crop care solutions across multiple categories, including insecticides such as chlorpyrifos, cypermethrin, imidacloprid, thiamethoxam, fipronil, and lambda-cyhalothrin; fungicides comprising mancozeb, tricyclazole, hexaconazole, azoxystrobin, and tebuconazole; herbicides including glyphosate, atrazine, pretilachlor, pendimethalin, 2,4-D, and bispyribac sodium; plant growth regulators, bio-stimulants, and specialized crop nutrition products; and technical-grade active ingredients alongside finished formulations in emulsifiable concentrate, suspension concentrate, wettable powder, water-dispersible granule, and soluble liquid formats. In addition to its branded and generic product lines, the company provides contract manufacturing, toll formulation, custom synthesis, and international regulatory registration support services for global agricultural chemical enterprises. Founded in 2002 and headquartered in New Delhi, India, Mahamaya Lifesciences operates manufacturing facilities in India and distributes its products through a nationwide domestic distribution network as well as export markets spanning Latin America, Africa, the Middle East, Southeast Asia, and Australia. In recent developments, the company has advanced its corporate expansion through its public market presence on the BSE under the ticker MAHALIFE, broadened its international footprint by securing new overseas product registrations and commercial distribution alliances, expanded its research and development portfolio to launch advanced combination crop protection chemistries and bio-rational formulations, and scaled its manufacturing and processing capacities to address growing domestic and export market demand.